Literature DB >> 1873448

Feasibility of conducting a lung-cancer chemoprevention trial among tin miners in Yunnan, P. R. China.

X Z Xuan1, A Schatzkin, B L Mao, P R Taylor, J Y Li, J Tangrea, S X Yao, Y L Qiao, C Giffen, M McAdams.   

Abstract

Tin miners in Yunnan Province in southern China have an extremely high rate of lung cancer, more than one percent per year among those at 'high risk' (40+ years old, with 10+ years of underground mining and/or smelting experience). The extraordinary lung cancer rates result from combined exposure to radon, arsenic, and tobacco smoking (cigarettes and/or bamboo water pipe). A study to determine the feasibility of conducting a large-scale, lung-cancer chemoprevention trial was conducted in 1986 among currently employed or retired miners from the Yunnan Tin Corporation in the city of Gejiu. The study was designed to answer four questions: (i) Could potentially eligible miners be identified and recruited? (ii) Could intervention agents be shipped successfully from the United States to the study area and be appropriately distributed? (iii) Would miners adequately adhere to the study protocol and comply with the intervention regimen? (iv) Could potential adverse effects be monitored and documented? The six-month feasibility study yielded affirmative answers to each of these questions. A roster of over 7,000 high-risk miners was compiled. Four agents (vitamin A, 25,000 IU; beta-carotene, 50 mg; vitamin E, 800 IU; and selenium, 400 micrograms) were administered daily with placebos to 350 miners according to a 2(4) factorial design. Adherence, assessed by pill counts and serum micronutrient levels, was approximately 90 percent. The findings from this preliminary study indicate that a full-scale, lung-cancer chemoprevention trial in this population is feasible.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873448     DOI: 10.1007/bf00056211

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  12 in total

1.  Relation of arsenic exposure to lung cancer among tin miners in Yunnan Province, China.

Authors:  P R Taylor; Y L Qiao; A Schatzkin; S X Yao; J Lubin; B L Mao; J Y Rao; M McAdams; X Z Xuan; J Y Li
Journal:  Br J Ind Med       Date:  1989-12

Review 2.  Diet and cancer.

Authors:  D G Zaridze
Journal:  World Rev Nutr Diet       Date:  1986       Impact factor: 0.575

3.  Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoid.

Authors:  J Gouveia; G Mathé; T Hercend; F Gros; G Lemaigre; G Santelli; J P Homasson; J P Gaillard; M Angebault; J P Bonniot; A Lededente; J Marsac; R Parrot; S Pretet
Journal:  Lancet       Date:  1982-03-27       Impact factor: 79.321

Review 4.  Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.

Authors:  C W Boone; G J Kelloff; W E Malone
Journal:  Cancer Res       Date:  1990-01-01       Impact factor: 12.701

5.  Factorial designs for randomized clinical trials.

Authors:  D P Byar; S Piantadosi
Journal:  Cancer Treat Rep       Date:  1985-10

6.  Relation of radon exposure and tobacco use to lung cancer among tin miners in Yunnan Province, China.

Authors:  Y L Qiao; P R Taylor; S X Yao; A Schatzkin; B L Mao; J Lubin; J Y Rao; M McAdams; X Z Xuan; J Y Li
Journal:  Am J Ind Med       Date:  1989       Impact factor: 2.214

7.  Determinants of plasma levels of beta-carotene and retinol. Skin Cancer Prevention Study Group.

Authors:  D W Nierenberg; T A Stukel; J A Baron; B J Dain; E R Greenberg
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

8.  An isocratic high-performance liquid chromatography method for the simultaneous analysis of plasma retinol, alpha-tocopherol, and various carotenoids.

Authors:  K W Miller; C S Yang
Journal:  Anal Biochem       Date:  1985-02-15       Impact factor: 3.365

9.  Some statistical considerations for design of cancer prevention trials.

Authors:  D P Byar
Journal:  Prev Med       Date:  1989-09       Impact factor: 4.018

10.  Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer.

Authors:  M S Menkes; G W Comstock; J P Vuilleumier; K J Helsing; A A Rider; R Brookmeyer
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

View more
  1 in total

1.  Drugs for preventing lung cancer in healthy people.

Authors:  Marcela Cortés-Jofré; José-Ramón Rueda; Claudia Asenjo-Lobos; Eva Madrid; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.